LADENBURG THALMANN FINANCIAL SERVICES INC. - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$0850
+142.9%
0.00%
Q1 2016$03500.0%0.00%
Q4 2015$0
-100.0%
3500.0%0.00%
Q3 2015$1,000
-75.0%
350
-54.8%
0.00%
Q2 2015$4,000
-33.3%
7750.0%0.00%
Q1 2015$6,000
-45.5%
775
-58.3%
0.00%
Q4 2014$11,000
+1000.0%
1,860
+644.0%
0.00%
Q3 2014$1,000
-50.0%
250
-37.0%
0.00%
Q2 2014$2,000
-33.3%
3970.0%0.00%
Q1 2014$3,000
+200.0%
397
+58.8%
0.00%
Q4 2013$1,000
-50.0%
2500.0%0.00%
Q3 2013$2,000
+100.0%
2500.0%0.00%
Q2 2013$1,0002500.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 525,000$2,956,0001.06%
First Light Asset Management, LLC 170,804$962,0000.82%
PFM Health Sciences, LP 5,047,119$28,415,0000.57%
Rhenman & Partners Asset Management AB 250,000$1,408,0000.55%
NEA Management Company, LLC 1,935,300$10,896,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 544,779$3,067,0000.43%
APEX CAPITAL, LLC 1,000,000$5,630,0000.37%
Partner Investment Management, L.P. 240,221$1,352,0000.31%
Hudson Bay Capital Management LP 1,002,405$5,644,0000.23%
BAILARD, INC. 243,300$1,370,0000.22%
View complete list of OREXIGEN THERAPEUTICS INC shareholders